PRICE T ROWE ASSOCIATES INC /MD/
Position in ZNTL — Zentalis Pharmaceuticals, Inc.
CIK 80255
BALTIMORE, MD
Position in ZNTL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$199,087
+$151,001 QoQ
Shares Held
41,049
-1.0% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 114 holders
Holding Since
Jun 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZNTL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. ZNTL ranks #252 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | TWST |
Twist Bioscience Corp
|
3,634,652 | $373,932,997 |
All Filings in ZNTL
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $199,087 | 41,049 | Shares | Defined | 2026-08-14 | |
| 2025-06-30 | $48,086 | 41,454 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $110,799 | 69,685 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $2,968,960 | 979,855 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,815,832 | 1,036,911 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,778,754 | 923,901 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $54,997,813 | 3,489,709 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $43,996,584 | 2,904,065 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $54,474,915 | 2,715,599 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $75,725,569 | 2,684,352 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $37,842,906 | 2,200,169 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $43,838,737 | 2,176,700 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $48,036,247 | 2,217,740 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $120,789,283 | 4,298,551 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $193,704,025 | 4,198,180 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $368,424,976 | 4,382,881 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $248,595,522 | 3,730,425 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $173,409,017 | 3,259,568 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $47,045,433 | 1,084,246 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $56,823,710 | 1,094,026 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $36,155,793 | 1,106,020 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $57,026,919 | 1,187,566 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||